Deepak Guttikonda, MD
Vascular Surgery · Indianapolis, INNPI 1073542346
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 319 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 319 payments — averaging $103.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$7K
- W. L. Gore & Associates, Inc.$6K
- Penumbra, Inc.$4K
- Philips North America LLC$2K
- Reflow Medical Inc$2K
- Abbott$2K
- plus $10K from 25 others
What the payments were for
- Consulting fees$2501%
- Travel & lodging$1,3834%
- Food & beverage$31,41095%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 66 | $7,386 |
| W. L. Gore & Associates, Inc. | 60 | $5,768 |
| Penumbra, Inc. | 22 | $3,973 |
| Philips North America LLC | 23 | $2,274 |
| Reflow Medical Inc | 15 | $2,081 |
| Abbott | 21 | $1,716 |
| Inari Medical, Inc. | 7 | $1,683 |
| Endologix LLC | 12 | $1,484 |
| Silk Road Medical, Inc. | 11 | $1,363 |
| Edwards Lifesciences | 24 | $998 |
| Cardiovascular Systems Inc. | 7 | $903 |
| Medtronic | 4 | $597 |
| Terumo Medical Corporation | 5 | $587 |
| Johnson & Johnson(2 entities) | 11 | $438 |
| Lemaitre Vascular, Inc. | 6 | $391 |
| Stryker | 2 | $270 |
| Shockwave Medical, Inc | 2 | $262 |
| Cook Medical LLC | 3 | $254 |
| Surmodics, Inc. | 1 | $177 |
| Bard Peripheral Vascular, Inc. | 1 | $132 |
| Cvrx, Inc. | 5 | $68 |
| EKOS Corporation | 1 | $45 |
| Corcym Inc | 1 | $31 |
| Pfizer | 2 | $30 |
| Bolton Medical Inc | 1 | $25 |
| Amgen | 1 | $22 |
| Teleflex LLC | 1 | $21 |
| AstraZeneca | 1 | $18 |
| Aroa Biosurgery Incorporated | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$3,154
- ENROUTE Transcarotid Neuroprotection System$3,152
- FLOWTRIEVER CATHETER, S$2,422
- GENERAL VASCULAR INTERVENTION$2,155
- ENROUTE Transcarotid Stent$1,404
- GORE VIABAHN VBX Balloon Expandable Endo$1,146
- CT THROMBECTOMY SYSTEM KIT$1,095
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$951
- Diamondback Peripheral$707
- (6571) Eagle Eye$655
- Penumbra System$618
- Alto Abdominal Stent Graft System$524
- IGT Devices Und$433
- Navicross$384
- GORE TAG Thoracic Branch Endoprosthesis$349
- Peripheral Orbital Atherectomy System$349
- Coronary Orbital Atherectomy System$349
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$341
- GORE PROPATEN Vascular Graft$328
- IN.PACT Admiral$326
How this compares
$33,043 in reported general payments places this provider in the 85th percentile of 71 vascular surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 81 | $91,825 |
| EliquisApixaban | 58 | $66,241 |
| ClopidogrelClopidogrel Bisulfate | 551 | $5,702 |
| Mupirocin | 78 | $520 |
| Enoxaparin Sodium | 11 | $470 |
| Atorvastatin Calcium | 20 | $196 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $150 |
| Warfarin Sodium | 14 | $94 |
| Prednisone | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $438 | $91,82581 claims |
| PfizerEliquis | $30 | $66,24158 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 71 vascular surgery providers in Indiana.
Other vascular surgery in Indianapolis
- Sajjad HussainIndianapolis$109K
- Andres FajardoIndianapolis$58K
- Brandon DowningIndianapolis$33K
- Jeffrey WeinbergerIndianapolis$20K
- Sarah StrotIndianapolis$15K
- Randy IrwinIndianapolis$14K
- Mary ZornIndianapolis$12K
- Charles KiellIndianapolis$10K
- Hanaa Dakour AridiIndianapolis$8K
- Richard OfsteinIndianapolis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.